STEPHANIE MOORE: Open Payments
NPI 1487298287 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,833 in 134 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $360 · 2025 $2,833
Food & beverage: $2,746Education: $88
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 43 | $652 |
| AstraZeneca Pharmaceuticals LP | 11 | $306 |
| HARMONY BIOSCIENCES LLC | 8 | $286 |
| Insmed, Inc. | 14 | $253 |
| GENZYME CORPORATION | 10 | $240 |
| Regeneron Healthcare Solutions, Inc. | 7 | $192 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $176 |
| Amgen Inc. | 7 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $116 |
| Viatris Specialty LLC | 5 | $108 |
Products named: DUPIXENT, TRELEGY ELLIPTA, AIRSUPRA, Arikayce, NUCALA, WAKIX, TEZSPIRE, GLASSIA.
Industry payments across AL — which companies pay providers there.
